Werewolf Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Updates Life Science Investing
Aligos Therapeutics Reports Recent Business Progress and First Quarter 2026 Financial Results Life Science Investing
Annexon Reports First Quarter 2026 Financial Results, Portfolio Progress and Key Anticipated Milestones Life Science Investing
AMGEN TO PRESENT AT THE BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE Life Science Investing
Arcturus Therapeutics Announces First Quarter 2026 Financial Results and Pipeline Progress Life Science Investing
BioRestorative Therapies Reports Expanded Phase 2 Blinded Dataset for BRTX-100 Showing Sustained Pain and Functional Improvements in Chronic Lumbar Disc Disease Life Science Investing
ME Therapeutics to Pitch at CSE Capital Tech Connect During Web Summit Vancouver Life Science Investing
Incyte Announces 24-Week Long-Term Data from Phase 3 TRuE-AD4 Trial of Opzelura® Cream in Adults with Moderate Atopic Dermatitis Life Science Investing
BriaCell Receives Positive Recommendation from Data Safety Monitoring Board for Phase 3 Study in Metastatic Breast Cancer
